Neurogenic bladder treatment electrical stimulation tactile assessment method and system, and wearable device

Abstract

The invention discloses a neurogenic bladder treatment electrical stimulation tactile assessment method and system and a wearable device. The system relates to the technical field of neurogenic bladder noninvasive nerve regulation treatment and electrical stimulation tactile assessment. Comprising the steps of collecting and analyzing neurogenic bladder treatment data, comprehensively analyzing and performing optimization adjustment. According to the invention, the electric pulse output by the stimulator unit acts on the specific neural electrode and captures and decodes the foot sole movement signal characteristics, the neurogenic bladder treatment data is collected and analyzed, and the position and stimulation parameters of the neural electrode are adaptively adjusted, so that the non-invasive treatment of the neurogenic bladder is realized, and the problem of deficiencies of the existing treatment technology is solved.

Description

Technical Field

[0001] The present invention relates to the technical field of electrical stimulation tactile assessment, and in particular to an electrical stimulation tactile assessment method, system and wearable device for neurogenic bladder treatment. Background Art

[0002] Neurogenic bladder usually has different clinical manifestations depending on the degree and location of neuropathy. For example, different segments and degrees of spinal cord injury can lead to different types of lower urinary tract dysfunction. 42% of patients with central spinal cord injury syndrome have neurogenic bladder. In patients with non-traumatic spinal cord injury, detrusor overactivity and detrusor-sphincter dyssynergia are the main causes of severe upper urinary tract damage. About 77.6% of patients with hereditary spastic paraplegia and 61% of patients with caudal regression syndrome will develop neurogenic bladder. Neurogenic bladder lower urinary tract symptoms include storage period, urination period, and post-urination symptoms with poor prognosis. Storage period symptoms include urgency, frequent urination, nocturia, urinary incontinence, enuresis, etc.; urination period symptoms include dysuria, incomplete bladder emptying, urine retention, urinary pain, etc.; it can cause a variety of long-term complications, the most serious of which are upper urinary tract damage and renal failure. Current treatments include assisted urination, such as Valsalva voiding, which has unstable effects; oral drug therapy, including drugs for treating detrusor overactivity and drugs for reducing urine production, has limited efficacy and side effects; surgical operations mainly focus on procedures to reconstruct urine storage function, such as bladder capacity expansion, and procedures to reconstruct urination function, such as detrusorplasty and sacral nerve implantation. These procedures have high risks of surgical trauma and are expensive. Currently, there is no non-invasive application solution for the treatment and evaluation of neurogenic bladder.

[0003] Existing methods for tactile assessment of bladder therapy with electrical stimulation are used to continuously monitor bladder volume through a wearable ultrasonic bladder volume monitor; and an integrated flexible ultrasound device is used to continuously monitor bladder volume, which combines a flexible, inflatable ultrasound transducer with miniaturized control electronics and has wireless data transmission capabilities.

[0004] For example, the wearable device and tactile feedback method, apparatus, and storage medium announced in the patent with announcement number: CN111399645B include: a touch panel, a touch electrode, a controller, and an adjustment module; wherein the touch panel is used to detect touch operations and generate touch signals according to the touch operations; the controller is connected to the touch panel, used to receive touch signals, obtain tactile parameters according to the touch signals, and output control signals according to the tactile parameters; the adjustment module is respectively connected to the controller and the tactile electrodes, used to generate electrical stimulation signals matching the tactile parameters according to the control signals, and output the electrical stimulation signals through the tactile electrodes.

[0005] For example, the electrical stimulation tactile feedback wearable system with kinesthetic mixed rendering disclosed in the patent application with publication number: CN117666778A includes: a host computer, a stimulation output module, a tactile feedback glove and a VR external device; the host computer is used to provide a virtual reality scene, and realize interaction with digital content according to the VR external device to generate tactile information; the tactile feedback glove includes a glove body, a fingertip tactile electrode array and a finger kinesthetic electrode array arranged on the glove body; the stimulation output module is connected to the tactile feedback glove, outputs a stimulation current to the tactile feedback glove according to the tactile information, activates part or all of the stimulation electrodes, so as to stimulate the fingers to produce kinesthetic feedback, and realizes a mixed rendering of kinesthetic and tactile.

[0006] However, in the process of implementing the technical solution of the invention in the embodiments of the present application, the present application found that the above technology has at least the following technical problems: This system is used in the application scenario of extracorporeal non-invasive treatment of neurogenic bladder. It lacks target coverage of the thoracic, lumbar, lumbar and iliac wing segments of the spinal cord. Due to the complexity of neurogenic bladder diseases, target coverage of nerve electrodes is very important. When the patient moves, the electrode moves, and the relative position between the electrode and the skin changes, which affects the accuracy of nerve stimulation and signal stability, resulting in unstable treatment effects. Transmission delays occur in the process of signal transmission from the stimulator unit to the nerve electrode unit. When multiple channels work simultaneously, the signal frequency characteristics between electronic components cause pulse waveform distortion or mutual influence between channels, affecting synchronization. There is a problem of insufficient accuracy in tactile evaluation of electrical stimulation for bladder treatment. Summary of the invention

[0007] The embodiments of the present application solve the problem of insufficient accuracy of wearable devices for neurogenic bladder treatment in the prior art by providing a method, system and wearable device for electrical stimulation tactile evaluation of neurogenic bladder treatment, thereby improving the accuracy of wearable devices for neurogenic bladder treatment.

[0008] The embodiment of the present application provides a tactile wearable device for electrical stimulation for treating neurogenic bladder, comprising the following steps: a stimulator unit, a neural electrode unit, a motion capture unit, a signal decoding unit, and a stimulation strategy unit. The motion capture unit monitors the patient's physiological activities and sends the data to the signal decoding unit. The signal decoding unit analyzes the data to determine whether stimulation is needed and the parameters of the stimulation. The stimulation strategy unit formulates a stimulation plan based on the output of the signal decoding unit and sends the plan to the stimulator unit. The stimulator unit generates corresponding electric pulses based on the received stimulation plan, and sends the electric pulses to the neural electrode unit through a wire or wirelessly. The neural electrode unit covers the thoracic vertebrae, lumbar vertebrae, sacrum and iliac wing, and transmits the electric pulses to the patient's nervous system to complete the stimulation process. The stimulator unit is a part that provides synchronous and asynchronous output of multi-channel stimulation pulses. The multi-channel electric pulses output by the stimulator are independently controllable, and the amplitude parameters, pulse width parameters, and stimulation frequency parameters of the multi-channel electric pulses are independently adjustable. During the stimulation, target screening and related motion capture are completed through the first layer of electrode sites and the second layer of electrode sites.

[0009] Furthermore, the electrical stimulation tactile evaluation method of the electrical stimulation tactile wearable device for neurogenic bladder treatment is characterized in that it includes the following steps: collecting and processing neurogenic bladder treatment data through the neural electrode unit and the motion capture unit in the electrical stimulation tactile wearable device for neurogenic bladder treatment; analyzing the neurogenic bladder treatment data through the signal decoding unit in the electrical stimulation tactile wearable device for neurogenic bladder treatment to obtain a neurogenic bladder treatment signal quality evaluation value and a neurogenic bladder treatment signal synchronization evaluation value; comprehensively analyzing the signal decoding unit in the electrical stimulation tactile wearable device for neurogenic bladder treatment to obtain the neurogenic bladder treatment signal accuracy Evaluation value; compare and analyze the neurogenic bladder treatment signal quality evaluation value with the first threshold of the neurogenic bladder treatment signal quality evaluation value through the stimulator unit and the stimulation strategy unit in the neurogenic bladder treatment electrical stimulation tactile wearable device, and optimize the neurogenic bladder treatment signal quality method; compare and analyze the neurogenic bladder treatment signal synchronization evaluation value with the second threshold of the neurogenic bladder treatment signal synchronization evaluation value, and optimize the neurogenic bladder treatment signal synchronization method; compare and analyze the neurogenic bladder treatment signal accuracy evaluation value with the comprehensive threshold of the neurogenic bladder treatment signal accuracy evaluation value, and optimize the neurogenic bladder treatment signal accuracy method.

[0010] Furthermore, the specific steps of collecting and processing neurogenic bladder treatment data are: collecting neurogenic bladder treatment raw data by contacting the soles, toes, soles, insteps, etc. through a neurogenic bladder treatment electrical stimulation tactile wearable device; cleaning and denoising the neurogenic bladder treatment raw data to obtain neurogenic bladder treatment data, and the neurogenic bladder treatment data includes neurogenic bladder treatment signal quality data and neurogenic bladder treatment signal synchronization data.

[0011] Furthermore, the specific process of obtaining the synchronization evaluation value of the neurogenic bladder treatment signal is as follows: obtaining the movement amplitude and angle characteristics of the preset neurogenic bladder treatment signal synchronization time detection point through the sensing devices at the sole, toes, sole and instep; obtaining the signal frequency characteristics of the preset neurogenic bladder treatment signal synchronization time detection point through the signal decoding unit; obtaining the signal transmission delay of the preset neurogenic bladder treatment signal synchronization time detection point through the signal decoding unit; obtaining the signal drift rate of the preset neurogenic bladder treatment signal synchronization time detection point through the signal decoding unit; obtaining the signal maximum phase of the preset neurogenic bladder treatment signal synchronization time detection point through the signal decoding unit; obtaining the signal minimum phase of the preset neurogenic bladder treatment signal synchronization time detection point through the signal decoding unit; obtaining the timestamp of the preset neurogenic bladder treatment signal synchronization time detection point through the signal decoding unit; the neurogenic bladder treatment signal synchronization data includes movement amplitude, signal frequency characteristics, signal transmission delay, signal drift rate, signal maximum phase, signal minimum phase and timestamp; and obtaining the neurogenic bladder treatment signal synchronization evaluation value according to the analysis of the neurogenic bladder treatment signal synchronization data.

[0012] Furthermore, the specific steps of comprehensively analyzing and obtaining the neurogenic bladder treatment signal accuracy evaluation value are as follows: obtaining the signal transmission rate of a preset neurogenic bladder treatment signal accuracy time detection point through a signal decoding unit; and obtaining the neurogenic bladder treatment signal accuracy evaluation value through comprehensive analysis of the neurogenic bladder treatment signal synchronization evaluation value, the signal transmission rate and the neurogenic bladder treatment signal quality evaluation value.

[0013] Furthermore, the specific steps of the method for optimizing and adjusting the neurogenic bladder treatment signal quality are as follows: if the neurogenic bladder treatment signal quality evaluation value is lower than or equal to the first threshold value of the neurogenic bladder treatment signal quality evaluation value, there is no need to optimize and adjust the neurogenic bladder treatment signal quality method; if the neurogenic bladder treatment signal quality evaluation value is higher than the first threshold value of the neurogenic bladder treatment signal quality evaluation value, then the difference between the neurogenic bladder treatment signal quality evaluation value and the first threshold value of the neurogenic bladder treatment signal quality evaluation value is used to match the corresponding adjustment plan in the neurogenic bladder treatment database.

[0014] Furthermore, the specific steps of the method for optimizing and adjusting the synchronization of neurogenic bladder treatment signals are as follows: if the neurogenic bladder treatment signal synchronization evaluation value is greater than or equal to the second threshold value of the neurogenic bladder treatment signal synchronization evaluation value, there is no need to optimize and adjust the method for optimizing and adjusting the neurogenic bladder treatment signal synchronization; if the neurogenic bladder treatment signal synchronization evaluation value is lower than the second threshold value of the neurogenic bladder treatment signal synchronization evaluation value, then the difference between the neurogenic bladder treatment signal synchronization evaluation value and the second threshold value of the neurogenic bladder treatment signal synchronization evaluation value is used to match the corresponding adjustment plan in the neurogenic bladder treatment database.

[0015] Furthermore, the specific steps of the method for optimizing and adjusting the accuracy of the neurogenic bladder treatment signal are as follows: extracting a comprehensive threshold of the neurogenic bladder treatment signal accuracy assessment value in the neurogenic bladder treatment database, and comparing the neurogenic bladder treatment signal accuracy assessment value with the comprehensive threshold of the neurogenic bladder treatment signal accuracy assessment value; if the neurogenic bladder treatment signal accuracy assessment value is greater than or equal to the comprehensive threshold of the neurogenic bladder treatment signal accuracy assessment value, there is no need to optimize and adjust the neurogenic bladder treatment signal accuracy method; if the neurogenic bladder treatment signal accuracy assessment value is lower than the comprehensive threshold of the neurogenic bladder treatment signal accuracy assessment value, then matching the corresponding adjustment plan in the neurogenic bladder treatment database through the difference between the neurogenic bladder treatment signal accuracy assessment value and the comprehensive threshold of the neurogenic bladder treatment signal accuracy assessment value.

[0016] The embodiment of the present application provides a neurogenic bladder treatment electrical stimulation tactile evaluation system, including: a neurogenic bladder treatment data collection module, a neurogenic bladder treatment data analysis module, a comprehensive analysis module and an optimization and adjustment module: the neurogenic bladder treatment data collection module is used to collect and process neurogenic bladder treatment data through a neural electrode unit and a motion capture unit in a neurogenic bladder treatment electrical stimulation tactile wearable device; the neurogenic bladder treatment data analysis module is used to analyze the neurogenic bladder treatment data through a signal decoding unit in a neurogenic bladder treatment electrical stimulation tactile wearable device to obtain a neurogenic bladder treatment signal quality evaluation value and a neurogenic bladder treatment signal synchronization evaluation value; the comprehensive ... The signal decoding unit in the wearable device comprehensively analyzes and obtains the accuracy evaluation value of the neurogenic bladder treatment signal; the optimization and adjustment module is used to compare and analyze the neurogenic bladder treatment signal quality evaluation value with the first threshold of the neurogenic bladder treatment signal quality evaluation value through the stimulator unit and the stimulation strategy unit in the neurogenic bladder treatment electrical stimulation tactile wearable device, and optimize the neurogenic bladder treatment signal quality method; compare and analyze the neurogenic bladder treatment signal synchronization evaluation value with the second threshold of the neurogenic bladder treatment signal synchronization evaluation value, and optimize the neurogenic bladder treatment signal synchronization method; compare and analyze the neurogenic bladder treatment signal accuracy evaluation value with the comprehensive threshold of the neurogenic bladder treatment signal accuracy evaluation value, and optimize the neurogenic bladder treatment signal accuracy method.

[0017] One or more technical solutions provided in the embodiments of the present application have at least the following technical effects or advantages: 1. It solves the technical difficulties of extracorporeal non-invasive treatment of neurogenic bladder and adopts an extracorporeal wearable non-invasive treatment solution to achieve non-contact and non-invasive treatment of nerves related to bladder function regulation, which is easy to use.

[0018] 2. By collecting and analyzing neurogenic bladder treatment data, the neurogenic bladder treatment signal quality evaluation value and the neurogenic bladder treatment signal synchronization evaluation value are obtained, and comprehensive analysis and optimization adjustments are performed, thereby improving the accuracy of wearable applications of neurogenic bladder electrical stimulation therapy and solving the problems of deficiencies in existing technologies.

[0019] 3. By collecting and analyzing neurogenic bladder treatment data, the neurogenic bladder treatment signal quality evaluation value and neurogenic bladder treatment signal synchronization evaluation value are obtained to ensure the effectiveness and reliability of the treatment signal, thereby improving the treatment effect. The equipment is simple and convenient to use, and is safer and has no side effects compared to traditional treatment methods.

[0020] 4. Obtain the accuracy assessment value of neurogenic bladder treatment signal through comprehensive analysis and make optimization adjustments to improve the treatment effect, reduce discomfort during treatment, and enhance the patient's treatment experience. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 A schematic diagram of the structure of a tactile wearable device for treating neurogenic bladder with electrical stimulation provided in an embodiment of the present application; Figure 2 A schematic diagram of a flow chart of a method for evaluating tactile sensation of electrical stimulation for treating neurogenic bladder provided in an embodiment of the present application; Figure 3 A schematic diagram of the structure of a tactile evaluation system for electrical stimulation of neurogenic bladder treatment provided in an embodiment of the present application; Figure 4 A rear view of the electrical stimulation tactile wearable device for treating neurogenic bladder provided in an embodiment of the present application; Figure 5 A schematic diagram of optimal electrode position finding and motion capture of a tactile wearable device for electrical stimulation of neurogenic bladder treatment provided in an embodiment of the present application; Figure 6 A schematic diagram of motion capture of an electrical stimulation tactile wearable device for treating neurogenic bladder provided in an embodiment of the present application; Figure 7 A schematic diagram of stimulation strategy and motion capture of a tactile wearable device for electrical stimulation of neurogenic bladder treatment provided in an embodiment of the present application; Figure 8 A schematic diagram of the rapid slope determination of a signal decoding unit of a tactile wearable device for electrical stimulation of neurogenic bladder treatment provided in an embodiment of the present application; Fig. 9 A schematic diagram of a 1 / 4 cycle integration method and a fast slope discrimination of a signal decoding unit of a tactile wearable device for electrical stimulation of neurogenic bladder treatment provided in an embodiment of the present application; Fig.10 A rear view of a human body application of an electrical stimulation tactile wearable device for treating neurogenic bladder provided in an embodiment of the present application; Fig.11 A side view of a human body application of an electrical stimulation tactile wearable device for treating neurogenic bladder provided in an embodiment of the present application. DETAILED DESCRIPTION

[0022] The embodiments of the present application provide a method, system and wearable device for tactile evaluation of electrical stimulation for neurogenic bladder treatment, thereby solving the limitation that there is no in vitro non-invasive treatment technology for neurogenic bladder in the prior art, and solving the problem of insufficient accuracy of neural target coverage in electrical stimulation for neurogenic bladder treatment. By collecting and analyzing neurogenic bladder treatment data, neurogenic bladder treatment signal quality evaluation values ​​and neurogenic bladder treatment signal synchronization evaluation values ​​are obtained, and comprehensive analysis and optimization adjustments are performed, thereby improving the accuracy of wearable applications of neurogenic bladder electrical stimulation for treatment and solving the deficiencies of the prior art.

[0023] The technical solution in the embodiment of the present application is to solve the above-mentioned problem of insufficient accuracy of wearable devices for treating neurogenic bladder. The overall idea is as follows: Through multi-target neural electrode coverage technology and neural target optimal patrol strategy, neurogenic bladder treatment data is synchronously collected and analyzed, and the neurogenic bladder treatment signal quality assessment value and neurogenic bladder treatment signal synchronization assessment value are obtained. Comprehensive analysis and optimization adjustments are performed, thereby improving the accuracy of wearable applications of neurogenic bladder electrical stimulation treatment.

[0024] In order to better understand the above technical solution, the above technical solution will be described in detail below in conjunction with the accompanying drawings and specific implementation methods.

[0025] like Figure 1 As shown, it is a structural schematic diagram of the electrical stimulation tactile wearable device for treating neurogenic bladder provided in an embodiment of the present application. The electrical stimulation tactile wearable device for treating neurogenic bladder provided in an embodiment of the present application comprises the following steps: a stimulator unit, a neural electrode unit, a motion capture unit, a signal decoding unit, and a stimulation strategy unit. The motion capture unit monitors the patient's physiological activities and sends the data to the signal decoding unit. The signal decoding unit analyzes the data to determine whether stimulation is needed and the parameters of the stimulation. The stimulation strategy unit formulates a stimulation plan according to the output of the signal decoding unit and sends the plan to the stimulator unit. The stimulator unit generates corresponding electric pulses according to the received stimulation plan and sends the electric pulses to the neural electrode unit through a wire or wirelessly. The neural electrode unit transmits the electric pulses to the patient's nervous system to complete the stimulation process. The stimulator unit is a part that provides synchronous and asynchronous output of multi-channel stimulation pulses. The multi-channel electric pulses output by the stimulator are independently controllable, and the amplitude parameters, pulse width parameters, and stimulation frequency parameters of the multi-channel electric pulses are independently adjustable.

[0026] In this embodiment, the neural electrode unit is a body surface electrode array including a plurality of contact electrodes and having different electrode spacings. The electrodes are connected to the stimulator unit without leads. The electrode unit includes a thoracic electrode unit acting on the thoracic vertebrae T11-T12 segment, with a thoracic electrode spacing of h1, a lumbar electrode unit acting on the lumbar vertebrae L1-L5 segment, with a lumbar electrode spacing of h2, a sacral electrode unit acting on the sacrum S1-S5, with a sacral electrode spacing of h3, and a transverse iliac crest electrode unit acting on the iliac crest. The neural stimulation signal is applied to the thoracic vertebrae T11-T12 segment, with a thoracic electrode spacing of h1, a lumbar electrode unit acting on the lumbar vertebrae L1-L5 segment, with a lumbar electrode spacing of h2, a sacral electrode unit acting on the sacrum S1-S5, with a sacral electrode spacing of h3, and a transverse iliac crest electrode unit acting on the iliac crest. The corresponding gated electrodes are generated. During motion capture, the electrodes T11-S5 will be patrolled quickly. The patrol strategy is to use T11 electrode, L2 electrode, L5 electrode, and S3 electrode as the first layer of electrode sites to determine the plantar movement characteristics caused by the above sites receiving stimulation signals, with the plantar flexion reaction as a mark; then use T12, L1, L3, L4, S1, S2, S4, and S5 electrodes as the second layer of electrode sites to determine the plantar movement characteristics caused by the above sites receiving stimulation signals, with the plantar flexion reaction as a mark, such as Figure 4 , Fig.10 and Fig.11 As shown, T11-T12 is the thoracic region; h1 is the distance between the thoracic regions; L1-L5 is the lumbar region; h2 is the distance between the lumbar regions; S1-S5 is the sacral region; h3 is the distance between the sacral regions; Q1 is the iliac crest; Q2 is the iliac crest, the neural electrode unit is an electrode array comprising a plurality of contact electrodes and having different electrode distances, and is used to transmit the multi-channel electrical pulses output by the stimulator unit to a specific region of the human body, the electrode is in contact with the human skin, and the electrode is connected to the stimulator unit without leads, the electrode unit comprises a thoracic electrode unit acting on the thoracic T11-T12 segment, the thoracic electrode distance is h1, and the electrode unit acts on the lumbar L1-L5 segment The lumbar electrode unit has a lumbar electrode spacing of h2, and acts on the sacrum S1-S5. The lateral iliac crest electrode unit has a sacral electrode spacing of h3, and acts on the iliac crest. During application, touch the position of the iliac wing with your hand, and it is easy to see the projection of the highest point of the iliac crest on the body surface. After selecting the iliac crest position, align the iliac crest electrode of the nerve electrode unit with the iliac wing horizontally, and the remaining electrodes can be attached along the direction of the spine. The electrodes of the spinal cord, lumbar sacral segment and iliac side are integrated, which is convenient for nerve positioning. The multi-site electrode coverage design can avoid re-tearing and secondary attachment due to electrode attachment displacement deviation; such as Figure 5 , Figure 6 and Figure 7As shown, the motion capture unit is a motion acquisition unit distributed at the sole of the foot and the sole and instep of the foot, which is used to collect and capture the plantar motion response after nerve stimulation. The captured signals include flexion and extension of the big toe, plantar flexion and eversion of the instep and sole of the foot. These actions are captured in parallel. The information elements include the time of action generation, instantaneous acceleration of the action, rotation angle, etc. This information is transmitted to the signal decoding unit wirelessly, avoiding the inconvenience caused by physical leads between the waist and the foot. The plantar motion is a reflex motion, and the trigger source is an external nerve stimulation signal worn outside the body. The nerve stimulation signal is generated between the corresponding selection electrodes. During the motion capture, the electrodes of T11-S5 will be patrolled quickly. The patrol strategy is to use T11 electrode, L2 electrode, L5 electrode, and S3 electrode as the first layer of electrode sites, judge the plantar motion characteristics caused by the above sites receiving the stimulation signal, and use the plantar flexion reaction as a mark; then use T12, L1, L3, L4, S1, S2, S4, S5 electrodes as the second The electrode sites of the layer are determined to determine the plantar movement characteristics caused by the above sites after receiving the stimulation signal, and the plantar flexion reaction of the plantar is used as a mark; the electrode selection time during the patrol of the electrode sites is recorded as t0, the stimulation pulse takes the pulse at the T11 electrode as the starting pulse, recorded as t1, the stimulation pulse width is t2-t1, and the pulse end time at the S5 electrode is t13; the plantar reflex movement is triggered after the stimulation signal, and the reflex movement cycle is hundreds of milliseconds to several seconds; the wireless transmission is an asynchronous transmission mode, and the wireless transmission is specifically divided into event frames and data frames. The captured signal quantity is marked as different event types, and the event type triggers the event frame, and the event frame triggers the data frame. The event frame interval is several milliseconds to tens of milliseconds, and the data frame adopts a short frame data structure, and the data frame interval is about 1 millisecond, so that all the information of the motion capture unit can be transmitted without omission. The purpose here is: when the biomarker phenomenon is triggered after stimulating different ganglia from T11 to S5, the movement characteristics of the human foot, etc. are a kind of biomarker, and these actions are recognized by attaching them to the body surface and non-invasively to obtain the required signals. Traditionally, evoked potentials are widely used to evaluate nerve function characteristics. They require monitoring of distal nerve potentials after stimulation. However, in order to reduce signal interference, needle-puncture electrodes are often used for subcutaneous monitoring, which is inconvenient and the equipment is not portable. Figure 8 and Fig. 9 As shown, , and It is the maximum phase angle of the signal at the 1 / 4 cycle, which can be equivalent to the signal phase slope, used to remove pseudo signals. Ref1, Ref2 and Ref3 are three preset comparison thresholds, used to remove pseudo signals, used in combination with the phase slope. If some pseudo signals meet the amplitude requirements but do not meet the phase slope requirements, they can be quickly removed. The signal decoding unit performs decoding analysis based on the information collected by the motion capture unit. The wireless transmission link has marked the type of the collected signal. The 1 / 4 cycle integration method is used to calculate the signal energy value in the [0-1 / 4] cycle. The fast slope judgment is used to calculate the discrete point slope difference at discrete points in the [0-1 / 4] cycle. By comparing the energy value and the slope change, the pseudo plantar motion signal can be quickly removed. Then, the action generation time, the instantaneous acceleration of the action, and the action rotation angle are numerically calculated. The collected values ​​can be understood as the discrete points x1, x2..xn. Combined with the calculation of the discrete point slope difference mentioned by comparing the energy value and the slope change, the slope difference is obtained, and then the action characteristics are reflected based on the slope difference, and the relative part of the plantar action is judged to be the big toe, the sole of the foot or the ankle joint. This can achieve fast, efficient and high-accuracy discrimination of motion characteristics, breaking through the analysis method that requires a complete cycle signal in conventional analysis schemes; the signal decoding link performs decoding calculations according to the position and time sequence of the first-layer electrode sites and the second-layer electrode sites. If the analyzed information elements are incomplete after the pseudo signal is eliminated, the stimulator will send an additional frame of neural stimulation signal to the electrode sites corresponding to the pseudo signal based on the position and time marks of the first-layer electrode sites and the second-layer electrode sites, so that the motion capture unit re-captures the motion, and the captured information elements are only the types that are missing after elimination. After data acquisition is completed, signal decoding is performed again until the information elements are completely decoded.

[0027] like Figure 2As shown, it is a flow chart of the method for tactile evaluation of electrical stimulation for neurogenic bladder treatment provided in an embodiment of the present application. The method for tactile evaluation of electrical stimulation for neurogenic bladder treatment provided in an embodiment of the present application comprises: collecting and processing neurogenic bladder treatment data through a neural electrode unit and a motion capture unit in a wearable electrical stimulation tactile device for neurogenic bladder treatment; analyzing the neurogenic bladder treatment data through a signal decoding unit in a wearable electrical stimulation tactile device for neurogenic bladder treatment to obtain a quality evaluation value of the neurogenic bladder treatment signal and a synchronization evaluation value of the neurogenic bladder treatment signal; comprehensively analyzing the neurogenic bladder treatment signal through a signal decoding unit in a wearable electrical stimulation tactile device for neurogenic bladder treatment to obtain a quality evaluation value of the neurogenic bladder treatment signal and a synchronization evaluation value of the neurogenic bladder treatment signal; Bladder treatment signal accuracy assessment value; compare and analyze the neurogenic bladder treatment signal quality assessment value with the first threshold of the neurogenic bladder treatment signal quality assessment value through the stimulator unit and the stimulation strategy unit in the neurogenic bladder treatment electrical stimulation tactile wearable device, and optimize the neurogenic bladder treatment signal quality method; compare and analyze the neurogenic bladder treatment signal synchronization assessment value with the second threshold of the neurogenic bladder treatment signal synchronization assessment value, and optimize the neurogenic bladder treatment signal synchronization method; compare and analyze the neurogenic bladder treatment signal accuracy assessment value with the comprehensive threshold of the neurogenic bladder treatment signal accuracy assessment value, and optimize the neurogenic bladder treatment signal accuracy method.

[0028] In this embodiment, the implementation process is as follows: a stimulator unit is used to provide synchronous and asynchronous output of multi-channel stimulation pulses, the number of stimulation channels can reach 16 channels, and the multi-channel electrical pulses output by the stimulator are independently controllable; the stimulation pulse acts on a specific electrode array in the neural electrode unit, which is used to transmit the multi-channel electrical pulses output by the stimulator unit to a specific area of ​​the human body, the electrode is in contact with the human skin, and the electrode is connected to the stimulator unit without a lead. During the application, the position of the iliac wing is touched by hand, and the projection of the highest point of the iliac crest on the body surface is easily seen. After selecting the iliac crest position, the iliac crest electrode of the neural electrode unit is horizontally aligned with the iliac wing, and the remaining electrodes are attached along the direction of the spine; after the stimulation pulse is output at a specific position, the motion acquisition unit distributed at the sole and the big toe of the foot and the motion acquisition unit distributed at the sole and the instep of the foot are attached to the skin surface, non-invasively, and are used to collect and capture the plantar movement after nerve stimulation. The captured signals include the flexion and extension of the big toe, plantar flexion and eversion of the sole of the foot, and the information elements include the time of action, instantaneous acceleration of the action, rotation angle, movement amplitude, signal frequency characteristics, signal transmission delay, signal drift rate, signal maximum phase, signal minimum phase and timestamp, etc. This information is highly consistent with the location of the nerve electrode and the stimulation parameters. The information is decoded and analyzed by the signal decoding unit. The analysis method uses the 1 / 4 cycle integration method and fast slope judgment to quickly eliminate pseudo-plantar movement signals, and can achieve fast, efficient and high-accuracy judgment of movement characteristics, breaking through the analysis method of the conventional analysis scheme that needs to obtain a complete cycle signal; the final analysis result will be fed back to the stimulation strategy unit, which will optimize the strategy of adaptive adjustment of stimulation parameters and stimulation electrode positions based on the output of the stimulator unit, so that the user is in the optimal stimulation output and clinical benefit state.

[0029] Furthermore, the specific steps of collecting and processing neurogenic bladder treatment data are: collecting neurogenic bladder treatment raw data by contacting the soles, toes, soles, insteps, etc. through neurogenic bladder treatment electrical stimulation tactile wearable devices; cleaning and denoising the neurogenic bladder treatment raw data to obtain neurogenic bladder treatment data, and the neurogenic bladder treatment data includes neurogenic bladder treatment signal quality data and neurogenic bladder treatment signal synchronization data.

[0030] In this embodiment, the electrical stimulation tactile wearable device for neurogenic bladder treatment is placed on the sole of the foot and other parts, and the collected motion characteristics are wirelessly transmitted to the wearable device for neurogenic bladder treatment for decoding and analysis.

[0031] Furthermore, the specific steps for obtaining the neurogenic bladder treatment signal quality evaluation value are as follows: obtaining the motion amplitude and angle characteristics of the preset neurogenic bladder treatment signal quality time detection point through the sensing devices at the sole, toes, sole and instep; obtaining the signal frequency characteristics of the preset neurogenic bladder treatment signal quality time detection point through the signal decoding unit; obtaining the stimulation frequency of the preset neurogenic bladder treatment signal quality time detection point through the neurostimulator signal decoding unit; obtaining the signal waveform center point amplitude value of the preset neurogenic bladder treatment signal quality time detection point through the signal decoding unit; obtaining the timestamp of the preset neurogenic bladder treatment signal quality time detection point through the signal decoding unit; the neurogenic bladder treatment signal quality data includes the motion amplitude, signal frequency characteristics, stimulation frequency, signal waveform center point amplitude value and timestamp; and obtaining the neurogenic bladder treatment signal quality evaluation value according to the neurogenic bladder treatment signal quality data analysis.

[0032] In this embodiment, the specific method for analyzing and obtaining the neurogenic bladder treatment signal quality evaluation value is as follows: ; ; ; ; ; ; The preset neurogenic bladder treatment signal quality time detection points are numbered in sequence. Indicates The number of the neurogenic bladder treatment signal quality time detection point under the neurogenic bladder treatment signal quality time detection section, , The total number of time detection points representing the quality of the neurogenic bladder treatment signal.

[0033] Divide the preset neurogenic bladder treatment signal quality time into neurogenic bladder treatment signal quality detection segments of the same length, Indicates the number of the neurogenic bladder treatment signal quality detection segment, , Indicates the total number of neurogenic bladder treatment signal quality detection segments.

[0034] Indicates The neurogenic bladder treatment signal quality assessment value at each neurogenic bladder treatment signal quality time detection point.

[0035] Indicates Motion artifact influence coefficient at each neurogenic bladder treatment signal quality time detection point.

[0036] Indicates The signal frequency characteristic influence coefficient at each neurogenic bladder treatment signal quality time detection point.

[0037] Indicates The stimulation frequency at each neurogenic bladder treatment signal quality time detection point. The stimulation frequency refers to the rate at which the current / voltage is turned on and off a specific number of times per second during neurogenic bladder electrical stimulation therapy. For example, a stimulation frequency of 20 Hz means 20 current / voltage pulses per second.

[0038] It represents the standard value of stimulation frequency, which is the preset standard value of stimulation frequency obtained from the neurogenic bladder treatment database, and can be the average value of stimulation frequency at the preset neurogenic bladder treatment signal quality time detection point from the historical database.

[0039] Indicates Signal fluctuation coefficient under the signal quality time detection period of neurogenic bladder treatment.

[0040] Indicates Timestamp of each neurogenic bladder treatment signal quality time detection point.

[0041] It represents the timestamp standard value, which is the preset timestamp standard value obtained from the neurogenic bladder treatment database, and can be the timestamp average value at the preset neurogenic bladder treatment signal quality time detection point from the historical database.

[0042] Indicates The amplitude value of the center point of the signal waveform in a neurogenic bladder treatment signal quality time detection segment.

[0043] It represents the standard value of the amplitude value of the center point of the signal waveform, which is the preset standard value of the amplitude value of the center point of the signal waveform obtained from the neurogenic bladder treatment database, and can be the average value of the amplitude value of the center point of the signal waveform under the preset neurogenic bladder treatment signal quality time detection section from the historical database.

[0044] It represents the standard value of signal waveform deviation, which is the preset standard value of signal waveform deviation obtained from the neurogenic bladder treatment database, and can be the average value of signal waveform deviation under the preset neurogenic bladder treatment signal quality time detection section from the historical database.

[0045] Indicates The amplitude of movement at each neurogenic bladder treatment signal quality time detection point.

[0046] It represents the standard value of motion amplitude, which is the preset standard value of motion amplitude obtained from the neurogenic bladder treatment database, and can be the average value of motion amplitude under the preset neurogenic bladder treatment signal quality time detection section from the historical database.

[0047] Indicates Signal frequency characteristics at three neurogenic bladder treatment signal quality time detection points.

[0048] It represents the standard value of signal frequency characteristics, which is the preset standard value of signal frequency characteristics obtained from the neurogenic bladder treatment database, and can be the average value of signal frequency characteristics at the preset neurogenic bladder treatment signal quality time detection point from the historical database.

[0049] is the preset stimulation frequency weight influencing factor obtained from the neurogenic bladder treatment database.

[0050] is the preset signal fluctuation coefficient weight influencing factor obtained from the neurogenic bladder treatment database.

[0051] are the preset timestamp weighted impact factors obtained from the neurogenic bladder treatment database.

[0052] are preset motion artifact impact factors obtained from the neurogenic bladder treatment database.

[0053] It is the influencing factor of the preset signal frequency characteristics obtained from the neurogenic bladder treatment database.

[0054] The preset stimulation frequency weight influence factor, the preset signal fluctuation coefficient weight influence factor and the preset timestamp weight influence factor are obtained through mapping relationships. For example, a mapping set of stimulation frequency, signal fluctuation coefficient and timestamp and their corresponding weights is established respectively through the relationship between the stimulation frequency, signal fluctuation coefficient and timestamp in the historical data. The corresponding preset stimulation frequency weight influence factor, preset signal fluctuation coefficient weight influence factor and preset timestamp weight influence factor in the mapping set are obtained by inputting the real-time stimulation frequency, signal fluctuation coefficient and timestamp.

[0055] The preset motion artifact influence factor and the preset signal frequency characteristic influence factor are obtained through mapping relationships. For example, a mapping set of motion artifacts and signal frequency characteristics and their corresponding weights is established respectively through the relationship between the motion artifacts and signal frequency characteristics in the historical data and the stimulation frequency. The corresponding preset motion artifact influence factor and preset signal frequency characteristic influence factor in the mapping set are obtained by inputting the real-time motion artifact and signal frequency characteristics.

[0056] Specifically, as shown in Table 1, in the treatment of neurogenic bladder, the neurogenic bladder treatment wearable device regulates bladder function through electrical pulse stimulation, and its stimulation strategy unit is designed to optimize the stimulation effect and improve the quality of neurogenic bladder treatment signals. For example, the neurogenic bladder signal quality evaluation value is related to the patient's response to electrical stimulation. Mn reflects the movement characteristics caused by electrical pulses. If Mn can effectively induce muscle activity that helps urination, the quality of neurogenic bladder signals will be improved. The stimulation strategy is as follows: STRn is the nth pair of stimulation pulse strategy. The T11-S5 region will have the characteristics of the arrangement and combination of multiple pairs of electrodes. Different combinations will bring different movement behaviors. The Mn value is assigned different factor coefficients based on the operating characteristics generated by different electrode combinations. The value range is [0, 1]. Mn is the coefficient corresponding to the movement characteristics captured after the nth pair of stimulation pulses. En is the coefficient corresponding to the nth pair of electrode regions. The T11-S5 region will have the characteristics of the arrangement and combination of multiple pairs of electrodes. The En value will give different proportional coefficients according to different arrangements and combinations. It is a proportional factor in the range of [0, 1]. An is the output stimulation intensity between the nth pair of electrodes. Fn is the output stimulation frequency between the nth pair of electrodes. Pwn is the output stimulation pulse width between the nth pair of electrodes. The stimulation pulse width refers to the electrical stimulation signal. The duration of a single pulse, Syn is the synchronization and asynchronous factor, An is the stimulation intensity between different electrodes, and its value is [0, 100]. Fn is the output frequency between different electrodes, and its value is [0, 50K]. Pwn is the pulse width between different electrodes, and its value is [0, 1000]. Syn is the stimulation synchronization and asynchronous factor, which is the compensation coefficient in the algorithm, and its value is [0, 1]. Num is the number of working electrodes. Multiple pairs of electrodes between T11-S5 electrodes can output electric pulses synchronously or asynchronously. STRn=Mn*En*An*Fn*Pwn*Syn*Num. The stimulation intensity, stimulation frequency, and stimulation pulse width between each electrode are independently adjustable. The adjustment strategy is that when the signal decoding unit results show that the ankle joint has the dorsiflexion reaction characteristics, it indicates that the electrode stimulation area is at the lumbar spine, and the priority electrodes are L4-L5. When the decoding results show that the big toe is plantar flexed, it indicates that the electrode stimulation area is at the sacrum, and the priority electrodes are S1-S2.

[0057] Specifically, functional weight factors are pre-assigned for motion parts and action characteristics. , , , , , First, the T11, L2, L5, and S3 electrodes are used as the first layer of electrode sites. These electrodes are distributed approximately equally in the span of the T11-S5 electrodes, which can be used for rapid initial screening of effective electrode areas. The plantar movement characteristics caused by the stimulation signals at the above sites are recorded as M1. , An_m in the M1 matrix is ​​the motion characteristic coefficient caused by the operation of the n-electrode and the m-electrode, which is related to the functional weight factor λ, that is, , the M1 matrix is ​​normalized according to each row and column to obtain the M1' matrix, and the eigenvector corresponding to the M1' matrix is ​​calculated , , the maximum value of the eigenvector is the preferred working electrode site.

[0058] Then, T12, L1, L3, L4, S1, S2, S4, and S5 electrodes were used as the second-layer electrode sites, and the motion characteristics were recorded as M2, which was used to finely select the electrode positions in the effective electrode area of ​​the initial screening of the M1 matrix. , An_m in the M2 matrix is ​​the motion characteristic coefficient caused by the operation of the n-electrode and the m-electrode, which is related to the functional weight factor About , the M2 matrix is ​​normalized according to each row and column to obtain the M2' matrix, and the eigenvector corresponding to the M2' matrix is ​​calculated , the maximum value of the eigenvector is the preferred working electrode site.

[0059] The discrete An_m in the M1' and M2' matrices are substituted into the matrix according to the electrode distribution position to form the M' matrix. The M' matrix is ​​the corresponding coefficient matrix of the motion features captured between the T11-S5 electrode arrays. , Mn_m in the M' matrix is ​​the motion characteristic coefficient between the n electrode and the m electrode, and the multiplication value of each row in the M' matrix is ​​calculated , the En coefficient is generated according to the product result, and the weight factor and , The coefficient values ​​of An, Fn, and Pwn are generated, and the control strategy finally transmitted to the stimulator is STRn=M'*En*An*Fn*Pwn*Syn*Num.

[0060]

[0061] Table 1 Treatment and regulation strategies for neurogenic bladder The higher the movement amplitude, the larger the action potential caused by the nerve control and the greater the signal characteristics; the stimulation frequency refers to the frequency of the stimulation signal applied externally to the neuromuscular part, and the stimulation frequency is related to the dynamic range of the neuromuscular activity controlled; the change in the signal frequency characteristic reflects the stability of the amplitude of the center point of the signal waveform; the timestamp is related to the dynamic range of the movement amplitude and reflects the movement amplitude characteristics.

[0062] There is a positive correlation between the square of the difference between the movement amplitude and the standard value of the movement amplitude and the signal quality assessment value of the neurogenic bladder treatment. The larger the square of the difference between the movement amplitude and the standard value of the movement amplitude, the larger the signal quality assessment value of the neurogenic bladder treatment; there is a positive correlation between the square of the difference between the signal frequency characteristics and the standard value of the signal frequency characteristics and the signal quality assessment value of the neurogenic bladder treatment. The larger the square of the difference between the signal frequency characteristics and the standard value of the signal frequency characteristics, the larger the signal quality assessment value of the neurogenic bladder treatment; there is a positive correlation between the absolute value of the stimulation frequency and the standard value of the stimulation frequency and the signal quality assessment value of the neurogenic bladder treatment. The rate does not match the foot-end action characteristics. The worse the quality of the neurogenic bladder treatment signal is, the greater the absolute value of the difference between the stimulation frequency and the standard value of the stimulation frequency is, and the greater the signal quality assessment value of the neurogenic bladder treatment is; there is a positive correlation between the square of the difference between the amplitude value of the center point of the signal waveform and the amplitude value of the center point of the signal waveform and the signal quality assessment value of the neurogenic bladder treatment signal. The more obvious the drift or offset of the signal is, the greater the square of the difference between the amplitude value of the center point of the signal waveform and the amplitude value of the center point of the signal waveform is, and the greater the signal quality assessment value of the neurogenic bladder treatment is; there is a positive correlation between the absolute value of the difference between the timestamp and the standard timestamp and the signal quality assessment value of the neurogenic bladder treatment signal.

[0063] Furthermore, the specific process of obtaining the synchronization evaluation value of the neurogenic bladder treatment signal is as follows: obtaining the movement amplitude and angle characteristics of the preset neurogenic bladder treatment signal synchronization time detection point through the sensing devices at the sole, toes, sole and instep; obtaining the signal frequency characteristics of the preset neurogenic bladder treatment signal synchronization time detection point through the signal decoding unit; obtaining the signal transmission delay of the preset neurogenic bladder treatment signal synchronization time detection point through the signal decoding unit; obtaining the signal drift rate of the preset neurogenic bladder treatment signal synchronization time detection point through the signal decoding unit; obtaining the signal maximum phase of the preset neurogenic bladder treatment signal synchronization time detection point through the signal decoding unit; obtaining the signal minimum phase of the preset neurogenic bladder treatment signal synchronization time detection point through the signal decoding unit; obtaining the timestamp of the preset neurogenic bladder treatment signal synchronization time detection point through the signal decoding unit; the neurogenic bladder treatment signal synchronization data includes movement amplitude, signal frequency characteristics, signal transmission delay, signal drift rate, signal maximum phase, signal minimum phase and timestamp; and obtaining the neurogenic bladder treatment signal synchronization evaluation value according to the analysis of the neurogenic bladder treatment signal synchronization data.

[0064] In this embodiment, the specific method for analyzing and obtaining the synchronization evaluation value of the neurogenic bladder treatment signal is as follows: ; ; ; ; ; ; The preset neurogenic bladder treatment signal synchronization time detection points are numbered in sequence. Indicates The number of the neurogenic bladder treatment signal synchronization time detection point under each neurogenic bladder treatment signal synchronization time detection segment, , Indicates the total number of synchronization time detection points of neurogenic bladder treatment signal.

[0065] Divide the preset neurogenic bladder treatment signal synchronization time into neurogenic bladder treatment signal synchronization detection segments of the same length of time, Indicates the number of the synchronization detection segment of the neurogenic bladder treatment signal. , Indicates the total number of synchronization detection segments of the neurogenic bladder treatment signal.

[0066] Indicates The neurogenic bladder treatment signal synchronization evaluation value of each neurogenic bladder treatment signal synchronization time detection point.

[0067] Indicates Motion artifact correction coefficient at the synchronization time detection point of neurogenic bladder treatment signal.

[0068] Indicates Signal frequency characteristic correction coefficient at the synchronization time detection point of neurogenic bladder treatment signal.

[0069] It represents the signal transmission delay threshold, which is a preset signal transmission delay threshold obtained from the neurogenic bladder treatment database, and can be the average value of the signal transmission delay at the preset neurogenic bladder treatment signal synchronization time detection point from the historical database.

[0070] Indicates Transmission delay under the synchronization time detection point of neurogenic bladder treatment signal.

[0071] It represents the signal drift deviation standard value, which is the preset signal drift deviation standard value obtained from the neurogenic bladder treatment database, and can be the average value of the signal drift deviation at the synchronous time detection point of the neurogenic bladder treatment signal preset in the historical database.

[0072] Indicates The signal drift rate at each neurogenic bladder treatment signal synchronization time detection point. In the process of treating neurogenic bladder, the signal drift rate refers to the unexpected and slow change of the signal baseline over time due to instrument or biological reasons during the signal acquisition process.

[0073] It represents the standard value of signal drift rate, which is the preset standard value of signal drift rate obtained from the neurogenic bladder treatment database, and can be the average value of signal drift rate at the synchronous time detection point of neurogenic bladder treatment signal preset from the historical database.

[0074] Indicates Signal phase synchronization coefficient under the synchronization time detection segment of neurogenic bladder treatment signal.

[0075] It represents the timestamp standard value, which is the preset timestamp standard value obtained from the neurogenic bladder treatment database, and can be the timestamp average value under the synchronous time detection point of the neurogenic bladder treatment signal preset in the historical database.

[0076] Indicates The timestamp of each neurogenic bladder treatment signal synchronization time detection point.

[0077] Indicates The movement amplitude at each neurogenic bladder treatment signal synchronization time detection point.

[0078] It represents the standard value of the movement amplitude, which is the preset standard value of the movement amplitude obtained from the neurogenic bladder treatment database, and can be the average value of the movement amplitude under the synchronous time detection section of the neurogenic bladder treatment signal preset in the historical database.

[0079] Indicates Signal frequency characteristics of neurogenic bladder treatment signals at synchronous time detection points.

[0080] It represents the standard value of signal frequency characteristics, which is the preset standard value of signal frequency characteristics obtained from the neurogenic bladder treatment database, and can be the average value of signal frequency characteristics at the synchronous time detection point of the preset neurogenic bladder treatment signal from the historical database.

[0081] Indicates The maximum phase of the signal under the synchronization time detection segment of the neurogenic bladder treatment signal.

[0082] Indicates The minimum phase of the signal under the synchronization time detection segment of the neurogenic bladder treatment signal.

[0083] It represents the signal phase deviation standard value, which is the preset signal phase deviation standard value obtained from the neurogenic bladder treatment database, and can be the signal phase deviation average value under the synchronous time detection section of the neurogenic bladder treatment signal preset in the historical database.

[0084] is the preset signal transmission delay weight influencing factor obtained from the neurogenic bladder treatment database.

[0085] is the preset signal drift rate weight influencing factor obtained from the neurogenic bladder treatment database.

[0086] is the weight influencing factor of the preset signal phase synchronization coefficient obtained from the neurogenic bladder treatment database.

[0087] are the preset timestamp weighted impact factors obtained from the neurogenic bladder treatment database.

[0088] are preset motion artifact correction factors obtained from the Neurogenic Bladder Treatment Database.

[0089] is the preset signal frequency characteristic correction factor obtained from the neurogenic bladder treatment database.

[0090] The preset signal transmission delay weight influence factor, the preset signal drift rate weight influence factor, the preset signal phase synchronization coefficient weight influence factor and the preset timestamp weight influence factor are obtained through mapping relationships. For example, a mapping set of signal transmission delay, signal drift rate, signal phase synchronization coefficient and timestamp and their corresponding weights is established respectively through the relationship between the signal transmission delay, signal drift rate, signal phase synchronization coefficient and timestamp in historical data and the signal amplitude amplitude. The corresponding preset signal transmission delay weight influence factor, preset signal drift rate weight influence factor, preset signal phase synchronization coefficient weight influence factor and preset timestamp weight influence factor in the mapping set are obtained by inputting the real-time signal transmission delay, signal drift rate, signal phase synchronization coefficient and timestamp.

[0091] The preset motion artifact correction factor and the preset signal frequency characteristic correction factor are obtained through a mapping relationship. For example, a mapping set of motion artifacts and signal frequency characteristics and their corresponding weights is established respectively through the relationship between the motion artifacts and signal frequency characteristics in the historical data and the signal drift rate. The corresponding preset motion artifact correction factor and preset signal frequency characteristic correction factor in the mapping set are obtained by inputting the real-time motion artifact and signal frequency characteristics.

[0092] Specifically, in the treatment of neurogenic bladder, the synchronization evaluation value of the neurogenic bladder treatment signal involves the synchronization of the stimulation signal, that is, whether the electrical pulses of different channels can be accurately output according to the preset synchronization strategy, which is directly related to the function of the stimulator unit. Synchronous output means that the electrical pulses of all channels are emitted at the same time or in a specific order.

[0093] The larger the movement amplitude, the larger the action potential caused by the nerve control and the greater the signal characteristics; signal transmission delay refers to the time difference between signal generation and recording by the detection system. The timestamp provides the time information of the signal occurrence. The larger the timestamp, the greater the signal transmission delay; the signal drift rate refers to the rate of change of the signal baseline over time, which affects the movement amplitude. The larger the signal drift rate, the greater the impact of the movement amplitude; the maximum signal phase and the minimum signal phase provide information about the change of the signal waveform over time.

[0094] There is a negative correlation between the square of the difference between the movement amplitude and the standard value of the movement amplitude and the synchronization evaluation value of the neurogenic bladder treatment signal. The larger the square of the difference between the movement amplitude and the standard value of the movement amplitude, the smaller the synchronization evaluation value of the neurogenic bladder treatment signal; there is a negative correlation between the square of the difference between the signal frequency characteristics and the standard value of the signal frequency characteristics and the synchronization evaluation value of the neurogenic bladder treatment signal. The larger the square of the difference between the signal frequency characteristics and the standard value of the signal frequency characteristics, the smaller the synchronization evaluation value of the neurogenic bladder treatment signal; there is a negative correlation between the signal transmission delay and the synchronization evaluation value of the neurogenic bladder treatment signal, which leads to the mismatch between the treatment signal and the foot end motion characteristics. The larger the signal transmission delay, the smaller the synchronization evaluation value of the neurogenic bladder treatment signal; the signal drift rate and the signal drift rate standard value There is a negative correlation between the absolute value of the difference and the synchronization evaluation value of the neurogenic bladder treatment signal, indicating that the signal baseline is unstable, which affects the synchronization of the signal. The larger the absolute value of the difference between the signal drift rate and the signal drift rate standard value, the smaller the synchronization evaluation value of the neurogenic bladder treatment signal; there is a negative correlation between the square of the difference between the maximum phase of the signal and the minimum phase of the signal and the synchronization evaluation value of the neurogenic bladder treatment signal. The larger the square of the difference between the maximum phase of the signal and the minimum phase of the signal, the smaller the synchronization evaluation value of the neurogenic bladder treatment signal; there is a negative correlation between the absolute value of the difference between the timestamp and the timestamp standard value and the synchronization evaluation value of the neurogenic bladder treatment signal. The larger the absolute value of the difference between the timestamp and the timestamp standard value, the more it affects the synchronization of the signal, and the smaller the synchronization evaluation value of the neurogenic bladder treatment signal is.

[0095] Furthermore, the specific steps of comprehensively analyzing and obtaining the neurogenic bladder treatment signal accuracy evaluation value are as follows: obtaining the signal transmission rate of a preset neurogenic bladder treatment signal accuracy time detection point through a signal decoding unit; and obtaining the neurogenic bladder treatment signal accuracy evaluation value through comprehensive analysis of the neurogenic bladder treatment signal synchronization evaluation value, the signal transmission rate and the neurogenic bladder treatment signal quality evaluation value.

[0096] In this embodiment, the specific method for analyzing and obtaining the accuracy evaluation value of the neurogenic bladder treatment signal is as follows: ; ; The preset neurogenic bladder treatment signal accuracy time detection points are numbered in sequence. Indicates the number of the time detection point of the neurogenic bladder treatment signal accuracy, , The total number of time detection points indicating the accuracy of the neurogenic bladder treatment signal.

[0097] Represents the accuracy assessment value of the neurogenic bladder treatment signal.

[0098] Indicates The neurogenic bladder treatment signal synchronization evaluation value of each neurogenic bladder treatment signal synchronization time detection point.

[0099] Indicates The signal transmission rate at each neurogenic bladder treatment signal accuracy time detection point.

[0100] It represents the signal transmission rate threshold, which is the preset signal transmission rate threshold obtained from the neurogenic bladder treatment database, and can be the average value of the signal transmission rate at the preset neurogenic bladder treatment signal accuracy time detection point from the historical database.

[0101] Indicates The neurogenic bladder treatment signal quality assessment value at each neurogenic bladder treatment signal quality time detection point.

[0102] It is the weight influencing factor of the preset neurogenic bladder treatment signal synchronization evaluation value obtained from the neurogenic bladder treatment database.

[0103] is the preset signal transmission rate weight influencing factor obtained from the neurogenic bladder treatment database.

[0104] It is the weight influencing factor of the preset neurogenic bladder treatment signal quality assessment value obtained from the neurogenic bladder treatment database.

[0105] The preset neurogenic bladder treatment signal synchronization evaluation value weight influencing factor, the preset signal transmission rate weight influencing factor and the preset neurogenic bladder treatment signal quality evaluation value weight influencing factor are obtained through mapping relationships. For example, a mapping set of neurogenic bladder treatment signal quality evaluation index, neurogenic bladder treatment signal synchronization evaluation index and signal transmission rate and their corresponding weights are established respectively through the relationship between the neurogenic bladder treatment signal quality evaluation index, the neurogenic bladder treatment signal synchronization evaluation index and the signal transmission rate in the historical data. The corresponding preset neurogenic bladder treatment signal synchronization evaluation value weight influencing factor, the preset signal transmission rate weight influencing factor and the preset neurogenic bladder treatment signal quality evaluation value weight influencing factor in the mapping set are obtained by inputting the real-time neurogenic bladder treatment signal quality evaluation index, the neurogenic bladder treatment signal synchronization evaluation index and the signal transmission rate.

[0106] Specifically, in the treatment of neurogenic bladder, for example, the accuracy evaluation value of the neurogenic bladder treatment signal is directly related to the accuracy of the electric pulse signal output by the stimulator unit, including whether the amplitude, width and frequency of the electric pulse are accurately output according to the preset parameters. If the electric pulse output by the stimulator unit is inaccurate, the accuracy of the neurogenic bladder treatment related signals will be reduced; the electrode array of the neural electrode unit accurately transmits the electric pulse to specific areas of the human body, and the accuracy of the electrode spacing and position is crucial to the transmission of the neurogenic bladder signal. If the electrode position or spacing is inaccurate, the neurogenic bladder signal transmission will be inaccurate, thereby affecting the accuracy of the neurogenic bladder signal.

[0107] The signal synchronization evaluation value of neurogenic bladder treatment refers to whether each channel can accurately output according to the preset synchronization strategy when the stimulator unit outputs multi-channel electrical pulses. The faster the signal transmission rate, the more the stimulation signal can reach the target position at the correct time, and the greater the signal synchronization evaluation value of neurogenic bladder treatment. The signal transmission rate refers to the speed at which the signal is generated, transmitted and then received. In neurogenic bladder treatment, the faster the signal transmission rate, the less signal delay can be, and the smaller the signal quality evaluation value of neurogenic bladder treatment. In neurogenic bladder treatment, the smaller the signal synchronization of neurogenic bladder treatment, the worse the signal quality of neurogenic bladder treatment, the greater the signal synchronization evaluation value of neurogenic bladder treatment, and the smaller the signal quality evaluation value of neurogenic bladder treatment.

[0108] There is a positive correlation between the synchronization evaluation value of the neurogenic bladder treatment signal and the accuracy evaluation value of the neurogenic bladder treatment signal. The higher the synchronization of the neurogenic bladder treatment signal, the more accurately and synchronously the stimulation signal can reach the target nerve at the predetermined time. The greater the synchronization evaluation value of the neurogenic bladder treatment signal, the greater the accuracy evaluation value of the neurogenic bladder treatment signal. There is a positive correlation between the signal transmission rate and the accuracy evaluation value of the neurogenic bladder treatment signal, which reduces the delay of the signal during the transmission process and ensures that the stimulation signal reaches the target position in time. The faster the signal transmission rate, the greater the accuracy evaluation value of the neurogenic bladder treatment signal. There is a negative correlation between the quality evaluation value of the neurogenic bladder treatment signal and the accuracy evaluation value of the neurogenic bladder treatment signal. The worse the quality of the neurogenic bladder treatment signal, the more it affects the synchronization of the neurogenic bladder treatment signal. The greater the quality evaluation value of the neurogenic bladder treatment signal, the smaller the accuracy evaluation value of the neurogenic bladder treatment signal.

[0109] Furthermore, the specific steps of optimizing and adjusting the method for neurogenic bladder treatment signal quality are as follows: if the neurogenic bladder treatment signal quality assessment value is lower than or equal to the first threshold value of the neurogenic bladder treatment signal quality assessment value, there is no need to optimize and adjust the method for neurogenic bladder treatment signal quality; if the neurogenic bladder treatment signal quality assessment value is higher than the first threshold value of the neurogenic bladder treatment signal quality assessment value, then the difference between the neurogenic bladder treatment signal quality assessment value and the first threshold value of the neurogenic bladder treatment signal quality assessment value is used to match the corresponding adjustment plan in the neurogenic bladder treatment database.

[0110] In this embodiment, assuming that the neurogenic bladder treatment signal quality evaluation value is 5, the first threshold of the neurogenic bladder treatment signal quality evaluation value obtained from the neurogenic bladder treatment database is 3, and the corresponding difference is 2. Then, the adjustment plan corresponding to the difference between the neurogenic bladder treatment signal quality evaluation value and the first threshold of the neurogenic bladder treatment signal quality evaluation value matched from the neurogenic bladder treatment database is 2. The adjustment plan is: adjust the stimulator electrode gating site and adjust the stimulation output intensity to achieve the purpose of reducing the neurogenic bladder treatment signal quality evaluation value.

[0111] Furthermore, the specific steps of optimizing and adjusting the method for synchronization of neurogenic bladder treatment signals are as follows: if the neurogenic bladder treatment signal synchronization evaluation value is greater than or equal to the second threshold value of the neurogenic bladder treatment signal synchronization evaluation value, there is no need to optimize and adjust the method for synchronization of neurogenic bladder treatment signals; if the neurogenic bladder treatment signal synchronization evaluation value is lower than the second threshold value of the neurogenic bladder treatment signal synchronization evaluation value, then the difference between the neurogenic bladder treatment signal synchronization evaluation value and the second threshold value of the neurogenic bladder treatment signal synchronization evaluation value is used to match the corresponding adjustment plan in the neurogenic bladder treatment database.

[0112] In this embodiment, assuming that the synchronization evaluation value of the neurogenic bladder treatment signal is 2, the second threshold value of the synchronization evaluation value of the neurogenic bladder treatment signal obtained from the neurogenic bladder treatment database is 3, and the corresponding difference is -1, then the adjustment scheme corresponding to the difference between the synchronization evaluation value of the neurogenic bladder treatment signal and the second threshold value of the synchronization evaluation value of the neurogenic bladder treatment signal matched from the neurogenic bladder treatment database is -1, and the adjustment scheme is: adjust the stimulation output frequency and adjust the sampling interval to achieve the purpose of improving the synchronization evaluation value of the neurogenic bladder treatment signal.

[0113] Furthermore, the specific steps of optimizing and adjusting the method for the accuracy of neurogenic bladder treatment signals are as follows: extracting a comprehensive threshold of a neurogenic bladder treatment signal accuracy assessment value from a neurogenic bladder treatment database, and comparing the neurogenic bladder treatment signal accuracy assessment value with the comprehensive threshold of the neurogenic bladder treatment signal accuracy assessment value; if the neurogenic bladder treatment signal accuracy assessment value is greater than or equal to the comprehensive threshold of the neurogenic bladder treatment signal accuracy assessment value, there is no need to optimize and adjust the method for the accuracy of neurogenic bladder treatment signals; if the neurogenic bladder treatment signal accuracy assessment value is lower than the comprehensive threshold of the neurogenic bladder treatment signal accuracy assessment value, then matching the corresponding adjustment plan in the neurogenic bladder treatment database through the difference between the neurogenic bladder treatment signal accuracy assessment value and the comprehensive threshold of the neurogenic bladder treatment signal accuracy assessment value.

[0114] In this embodiment, assuming that the accuracy assessment value of the neurogenic bladder treatment signal is 1, the comprehensive threshold of the neurogenic bladder treatment signal accuracy assessment value obtained from the neurogenic bladder treatment database is 3, and the corresponding difference is -2, then the adjustment plan corresponding to the difference between the neurogenic bladder treatment signal accuracy assessment value and the comprehensive threshold of the neurogenic bladder treatment signal accuracy assessment value matched from the neurogenic bladder treatment database is -2, and the adjustment plan is: adjust the sampling rate and the sampling interval to achieve the purpose of improving the accuracy assessment value of the neurogenic bladder treatment signal.

[0115] like Figure 3As shown, it is a structural schematic diagram of the electrical stimulation tactile evaluation system for neurogenic bladder treatment provided in an embodiment of the present application. The electrical stimulation tactile evaluation system for neurogenic bladder treatment provided in an embodiment of the present application includes: a neurogenic bladder treatment data collection module, a neurogenic bladder treatment data analysis module, a comprehensive analysis module and an optimization adjustment module: the neurogenic bladder treatment data collection module is used to collect and process the neurogenic bladder treatment data through the neural electrode unit and the motion capture unit in the neurogenic bladder treatment electrical stimulation tactile wearable device; the neurogenic bladder treatment data analysis module is used to analyze the neurogenic bladder treatment data through the signal decoding unit in the neurogenic bladder treatment electrical stimulation tactile wearable device to obtain a neurogenic bladder treatment signal quality evaluation value and a neurogenic bladder treatment signal synchronization evaluation value; the comprehensive analysis module It is used to obtain the accuracy evaluation value of the neurogenic bladder treatment signal through comprehensive analysis by the signal decoding unit in the neurogenic bladder treatment electrical stimulation tactile wearable device; the optimization and adjustment module is used to compare and analyze the neurogenic bladder treatment signal quality evaluation value with the first threshold of the neurogenic bladder treatment signal quality evaluation value through the stimulator unit and the stimulation strategy unit in the neurogenic bladder treatment electrical stimulation tactile wearable device, and optimize the neurogenic bladder treatment signal quality method; compare and analyze the neurogenic bladder treatment signal synchronization evaluation value with the second threshold of the neurogenic bladder treatment signal synchronization evaluation value, and optimize the neurogenic bladder treatment signal synchronization method; compare and analyze the neurogenic bladder treatment signal accuracy evaluation value with the comprehensive threshold of the neurogenic bladder treatment signal accuracy evaluation value, and optimize the neurogenic bladder treatment signal accuracy method.

[0116] It will be appreciated by those skilled in the art that embodiments of the present invention may be provided as methods, systems, or computer program products. Therefore, the present invention may take the form of a complete hardware embodiment, a complete software embodiment, or an embodiment combining software and hardware. Furthermore, the present invention may take the form of a computer program product implemented on one or more computer-usable storage media (including but not limited to disk storage, CD-ROM, optical storage, etc.) containing computer-usable program code.

[0117] The present invention is described with reference to flowcharts and / or block diagrams of systems, devices (systems), and computer program products according to embodiments of the present invention. It should be understood that each process and / or block in the flowchart and / or block diagram, as well as the combination of processes and / or blocks in the flowchart and / or block diagram, can be implemented by computer program instructions. These computer program instructions can be provided to a processor of a general-purpose computer, a special-purpose computer, an embedded processor, or other programmable data processing device to produce a machine, so that the instructions executed by the processor of the computer or other programmable data processing device generate instructions for implementing the processes in the flowchart and / or block diagram. Figure 1 A process or multiple processes and / or boxes Figure 1 A device that provides the functions specified in a block or multiple blocks.

[0118] These computer program instructions may also be stored in a computer-readable memory capable of directing a computer or other programmable data processing device to operate in a specific manner, so that the instructions stored in the computer-readable memory produce an article of manufacture comprising an instruction device, which implements the process Figure 1 A process or multiple processes and / or boxes Figure 1 A function specified in one or more boxes.

[0119] These computer program instructions can also be loaded onto a computer or other programmable data processing device so that a series of operating steps are executed on the computer or other programmable device to produce a computer-implemented process, thereby providing instructions for implementing the process. Figure 1 A process or multiple processes and / or boxes Figure 1 The steps for the functions specified in one or more boxes.

[0120] Although the preferred embodiments of the present invention have been described, those skilled in the art may make other changes and modifications to these embodiments once they have learned the basic creative concept. Therefore, the appended claims are intended to be interpreted as including the preferred embodiments and all changes and modifications that fall within the scope of the present invention.

[0121] Obviously, those skilled in the art may make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.

Claims

1. A tactile wearable device for treating neurogenic bladder with electrical stimulation, characterized in that: include: A stimulator unit, a neural electrode unit, a motion capture unit, a signal decoding unit, and a stimulation strategy unit. The motion capture unit monitors the patient's physiological activities and sends the data to the signal decoding unit. The signal decoding unit analyzes the data to determine whether stimulation is needed and the parameters of the stimulation. The stimulation strategy unit formulates a stimulation plan based on the output of the signal decoding unit and sends the plan to the stimulator unit. The stimulator unit generates corresponding electric pulses based on the received stimulation plan, and sends the electric pulses to the neural electrode unit through wires or wirelessly. The neural electrode unit covers the thoracic vertebrae, lumbar vertebrae, sacrum and iliac wing, and transmits the electric pulses to the patient's nervous system to complete the stimulation process. The stimulator unit is a part that provides synchronous and asynchronous output of multi-channel stimulation pulses. The multi-channel electric pulses output by the stimulator are independently controllable, and the amplitude parameters, pulse width parameters, and stimulation frequency parameters of the multi-channel electric pulses are independently adjustable. During stimulation, target screening and related motion capture are completed through the first layer of electrode sites and the second layer of electrode sites.

2. The electrical stimulation tactile evaluation method applied to the electrical stimulation tactile wearable device for treating neurogenic bladder as claimed in claim 1, characterized in that: The following steps are involved: Collect and process neurogenic bladder treatment data through the neural electrode unit and motion capture unit in the neurogenic bladder treatment electrical stimulation tactile wearable device; The neurogenic bladder treatment data is analyzed by a signal decoding unit in the neurogenic bladder treatment electrical stimulation tactile wearable device to obtain a neurogenic bladder treatment signal quality evaluation value and a neurogenic bladder treatment signal synchronization evaluation value; The accuracy evaluation value of the neurogenic bladder treatment signal is obtained through comprehensive analysis of the signal decoding unit in the neurogenic bladder treatment electrical stimulation tactile wearable device; By comparing and analyzing the neurogenic bladder treatment signal quality assessment value with the first threshold of the neurogenic bladder treatment signal quality assessment value through the stimulator unit and the stimulation strategy unit in the neurogenic bladder treatment electrical stimulation tactile wearable device, the neurogenic bladder treatment signal quality method is optimized and adjusted; the neurogenic bladder treatment signal synchronization assessment value and the neurogenic bladder treatment signal synchronization assessment value second threshold are compared and analyzed, and the neurogenic bladder treatment signal synchronization method is optimized and adjusted; the neurogenic bladder treatment signal accuracy assessment value and the neurogenic bladder treatment signal accuracy assessment value comprehensive threshold are compared and analyzed, and the neurogenic bladder treatment signal accuracy method is optimized and adjusted.

3. The electrical stimulation tactile evaluation method according to claim 2, characterized in that: The specific steps of collecting and processing neurogenic bladder treatment data are as follows: The original data of neurogenic bladder treatment is collected by touching the soles, toes, soles, insteps, etc. with the neurogenic bladder treatment electrical stimulation tactile wearable device; The original neurogenic bladder treatment data is cleaned and denoised to obtain neurogenic bladder treatment data, wherein the neurogenic bladder treatment data includes neurogenic bladder treatment signal quality data and neurogenic bladder treatment signal synchronization data.

4. The electrical stimulation tactile evaluation method according to claim 2, characterized in that: The specific steps of obtaining the neurogenic bladder treatment signal quality evaluation value are as follows: The motion amplitude and angle characteristics of the preset neurogenic bladder treatment signal quality time detection point are obtained through the sensor devices at the sole, toes, sole and instep; The signal frequency characteristics of the preset neurogenic bladder treatment signal quality time detection point are obtained through the signal decoding unit; The stimulation frequency of the preset neurogenic bladder treatment signal quality time detection point is obtained by the neurostimulator; The signal waveform center point amplitude value of the preset neurogenic bladder treatment signal quality time detection point is obtained through the signal decoding unit; Obtaining a timestamp of a preset neurogenic bladder treatment signal quality time detection point through a signal decoding unit; The neurogenic bladder treatment signal quality data includes movement amplitude, signal frequency characteristics, stimulation frequency, signal waveform center point amplitude value and timestamp; The neurogenic bladder treatment signal quality assessment value is obtained based on the neurogenic bladder treatment signal quality data analysis.

5. The electrical stimulation tactile evaluation method according to claim 2, characterized in that: The specific process of obtaining the synchronization evaluation value of the neurogenic bladder treatment signal is as follows: The motion amplitude and angle characteristics of the preset neurogenic bladder treatment signal synchronization time detection point are obtained through the sensor devices at the sole, toes, sole and instep; The signal frequency characteristics of the preset neurogenic bladder treatment signal synchronization time detection point are obtained through the signal decoding unit; The signal transmission delay of the preset neurogenic bladder treatment signal synchronization time detection point is obtained through the signal decoding unit; The signal drift rate of the preset neurogenic bladder treatment signal synchronization time detection point is obtained through the signal decoding unit; The maximum phase of the signal of the preset neurogenic bladder treatment signal synchronization time detection point is obtained through the signal decoding unit; The signal minimum phase of the preset neurogenic bladder treatment signal synchronization time detection point is obtained through the signal decoding unit; Obtaining the timestamp of the preset neurogenic bladder treatment signal synchronization time detection point through the signal decoding unit; The neurogenic bladder treatment signal synchronization data includes movement amplitude, signal frequency characteristics, signal transmission delay, signal drift rate, signal maximum phase, signal minimum phase and time stamp; The neurogenic bladder treatment signal synchronization evaluation value is obtained based on the neurogenic bladder treatment signal synchronization data analysis.

6. The electrical stimulation tactile evaluation method according to claim 2, characterized in that: The specific steps of comprehensively analyzing and obtaining the accuracy evaluation value of the neurogenic bladder treatment signal are as follows: The signal transmission rate of the preset neurogenic bladder treatment signal accuracy time detection point is obtained through the signal decoding unit; The accuracy assessment value of the neurogenic bladder treatment signal is obtained through comprehensive analysis of the neurogenic bladder treatment signal synchronization assessment value, signal transmission rate and neurogenic bladder treatment signal quality assessment value.

7. The electrical stimulation tactile evaluation method according to claim 2, characterized in that: The specific steps of the method for optimizing and adjusting the quality of neurogenic bladder treatment signals are as follows: If the neurogenic bladder treatment signal quality assessment value is lower than or equal to the neurogenic bladder treatment signal quality assessment value first threshold, there is no need to optimize and adjust the neurogenic bladder treatment signal quality method; If the neurogenic bladder treatment signal quality assessment value is higher than the first threshold value of the neurogenic bladder treatment signal quality assessment value, the corresponding adjustment plan in the neurogenic bladder treatment database is matched through the difference between the neurogenic bladder treatment signal quality assessment value and the first threshold value of the neurogenic bladder treatment signal quality assessment value.

8. The electrical stimulation tactile evaluation method according to claim 2, characterized in that: The specific steps of the method for optimizing and adjusting the synchronization of neurogenic bladder treatment signals are as follows: If the neurogenic bladder treatment signal synchronization evaluation value is greater than or equal to the neurogenic bladder treatment signal synchronization evaluation value second threshold value, there is no need to optimize and adjust the neurogenic bladder treatment signal synchronization method; If the neurogenic bladder treatment signal synchronization evaluation value is lower than the second threshold value of the neurogenic bladder treatment signal synchronization evaluation value, the corresponding adjustment plan in the neurogenic bladder treatment database is matched through the difference between the neurogenic bladder treatment signal synchronization evaluation value and the second threshold value of the neurogenic bladder treatment signal synchronization evaluation value.

9. The electrical stimulation tactile evaluation method according to claim 2, characterized in that: The specific steps of the method for optimizing and adjusting the accuracy of neurogenic bladder treatment signals are as follows: Extracting a comprehensive threshold value of the neurogenic bladder treatment signal accuracy assessment value from a neurogenic bladder treatment database, and comparing the neurogenic bladder treatment signal accuracy assessment value with the comprehensive threshold value of the neurogenic bladder treatment signal accuracy assessment value; If the neurogenic bladder treatment signal accuracy assessment value is greater than or equal to the neurogenic bladder treatment signal accuracy assessment value comprehensive threshold, there is no need to optimize and adjust the neurogenic bladder treatment signal accuracy method; If the neurogenic bladder treatment signal accuracy assessment value is lower than the neurogenic bladder treatment signal accuracy assessment value comprehensive threshold, the corresponding adjustment plan in the neurogenic bladder treatment database is matched through the difference between the neurogenic bladder treatment signal accuracy assessment value and the neurogenic bladder treatment signal accuracy assessment value comprehensive threshold.

10. A tactile evaluation system for electrical stimulation of neurogenic bladder treatment, characterized in that: The method comprises the following steps: a neurogenic bladder treatment data acquisition module, a neurogenic bladder treatment data analysis module, a comprehensive analysis module and an optimization adjustment module: The module for collecting neurogenic bladder treatment data is used to collect and process neurogenic bladder treatment data through the neural electrode unit and the motion capture unit in the neurogenic bladder treatment electrical stimulation tactile wearable device; The neurogenic bladder treatment data analysis module is used to analyze the neurogenic bladder treatment data through the signal decoding unit in the neurogenic bladder treatment electrical stimulation tactile wearable device to obtain the neurogenic bladder treatment signal quality evaluation value and the neurogenic bladder treatment signal synchronization evaluation value; The comprehensive analysis module is used to obtain the accuracy evaluation value of the neurogenic bladder treatment signal through comprehensive analysis of the signal decoding unit in the neurogenic bladder treatment electrical stimulation tactile wearable device; The optimization and adjustment module is used to compare and analyze the neurogenic bladder treatment signal quality assessment value with the first threshold of the neurogenic bladder treatment signal quality assessment value through the stimulator unit and the stimulation strategy unit in the neurogenic bladder treatment electrical stimulation tactile wearable device, and optimize and adjust the neurogenic bladder treatment signal quality method; compare and analyze the neurogenic bladder treatment signal synchronization assessment value with the second threshold of the neurogenic bladder treatment signal synchronization assessment value, and optimize and adjust the neurogenic bladder treatment signal synchronization method; compare and analyze the neurogenic bladder treatment signal accuracy assessment value with the comprehensive threshold of the neurogenic bladder treatment signal accuracy assessment value, and optimize and adjust the neurogenic bladder treatment signal accuracy method.

Images